Greenlane Holdings is still technically operating. It’s still listed on Nasdaq under the ticker GNLN. It’s still putting out press releases. But if you look at the actual numbers, the picture looks very different from a functioning business.
An $85 million net loss in 2025. A 1-for-750 reverse stock split. A sudden pivot from cannabis accessories to cryptocurrency. These are not signs of a company working through a rough patch — they are signs of a company fighting to survive.
This article breaks down what Greenlane actually is, what the financials show, what the BeraStrategy pivot means, and how to tell if the company is getting closer to shutting down entirely.
What Greenlane Holdings Actually Does
Greenlane was founded as a global distributor of premium cannabis accessories, child-resistant packaging, and specialty vaporization products. It sells through specialty and convenience retailers as well as direct-to-consumer channels.
The company describes itself as one of the premier global sellers in its category, and it has operated as a publicly traded company on Nasdaq for several years. At its core, it was a physical goods distribution business built around the legal cannabis market.
That core business is now shrinking fast. And in its place, Greenlane has introduced something called BeraStrategy — a digital asset treasury play built around a blockchain called Berachain. The company is, in effect, trying to become two very different things at once, and struggling badly at both.
Greenlane’s Financial Losses Are Not a Minor Problem
The numbers from Greenlane’s 2025 annual report are hard to spin positively. Net revenue came in at approximately $4.4 million. That is an extremely small revenue base for a distribution business with real operating costs.
The net loss attributable to Greenlane in 2025 was over $85 million. In 2024, that loss was around $17 million. That means losses grew by roughly five times in a single year.
Net loss per share exceeded $11 in 2025. When a company loses that much relative to the money it brings in, it cannot survive on its own. It needs outside financing — constantly. That is exactly what Greenlane has been doing.
In February 2025, the company closed a $25 million private placement of common stock and warrants at $1.19 per unit. That cash injection helps keep the lights on, but it does not fix the underlying problem: the business is spending far more than it earns, and the gap is getting wider, not narrower.
A company living entirely on outside financing is not stable. It stays alive only as long as investors are willing to keep funding it. When that stops, so does the company.
The 1-for-750 Reverse Stock Split Explained
In June 2025, Greenlane’s board approved a 1-for-750 reverse stock split of its Class A common shares, effective June 26, 2025. That ratio is not a typo — it is one of the most extreme reverse splits you will see from a Nasdaq-listed company.
Before the split, the company had approximately 1.04 billion Class A shares outstanding. After the split, that number dropped to roughly 1.39 million shares. The share price at the time was around $0.01.
Here is the simple version of what happened: Nasdaq requires companies to maintain a minimum bid price of $1.00 per share to stay listed. When your stock trades at a penny, you fail that requirement. A reverse split artificially raises the price per share to meet the rule.
Think of it this way. If you hold 750 shares worth $0.01 each, your total is $7.50. After a 1-for-750 split, you hold 1 share worth $7.50. Nothing changed for you financially — and nothing changed for the company either. The business is exactly as healthy or unhealthy as it was before the split.
A reverse split does not fix the business. It just changes the denomination of shares so the company can stay listed. The fact that Greenlane needed a 1-for-750 ratio to get there tells you just how far the stock had fallen.
When a company keeps needing reverse splits and equity raises to stay alive, that is a sign of ongoing capital dependency — not recovery.
What BeraStrategy Is and Why It Raises Questions
BeraStrategy is Greenlane’s Berachain-focused digital asset treasury strategy. Berachain is a relatively new blockchain that uses a mechanism called “Proof of Liquidity.” The idea is that Greenlane deploys capital into the Berachain ecosystem and earns yield or token-based upside in return.
To be direct about what this means: a company that was selling bongs and child-resistant packaging is now operating like a crypto-focused treasury fund.
The comparison that comes to mind is a struggling regional retailer suddenly deciding to pivot into running a niche hedge fund. The upside could theoretically be large. But the company has walked away from its original competency and taken on a completely different risk profile.
Berachain is an emerging blockchain. The regulatory environment around digital assets remains uncertain. Greenlane is heavily concentrated in one ecosystem rather than running a diversified operation. And based on the 2025 financial results, the digital asset strategy has contributed to volatility and losses, not stability.
The risks tied to BeraStrategy are not small. Market swings in crypto can be severe. Regulatory changes at the SEC or CFTC level could affect how these strategies operate. And betting heavily on a single blockchain’s growth is a high-stakes move for any company — let alone one that is already losing tens of millions of dollars per year.
BeraStrategy is not confirmed to be a scam or a fraud. But it is an enormous strategic gamble, and the numbers so far do not suggest it is paying off.
Is Greenlane Going Out of Business Right Now?
As of the information available in mid-2025, Greenlane has not filed for bankruptcy. There has been no official liquidation announcement. The company is still communicating with investors, still selling its legacy accessories products, and still pursuing the BeraStrategy initiative.
But “not bankrupt yet” and “financially healthy” are very different things.
Greenlane shows multiple indicators of serious distress: massive net losses, a collapsing share price, reliance on repeated equity raises to fund operations, a core business that is shrinking, and a speculative pivot into crypto that adds more risk than it has so far reduced.
There is also the Nasdaq delisting issue to consider. Delisting does not shut a company down, but it makes raising capital harder, reduces investor visibility, and pushes a company onto OTC markets where trading is thinner and more expensive. At one point before the reverse split, Greenlane was reportedly planning an appeal before a scheduled delisting date. Whether the reverse split resolved that fully remains a key detail to watch.
For customers — retailers ordering packaging or vaporizer accessories from Greenlane — the short-term picture might look normal. Orders may still ship. Business may seem fine at the operational level. But financial distress tends to show up in markets before it shows up at the warehouse door. If Greenlane cannot secure future financing, that gap closes quickly.
How to Monitor Whether Greenlane Survives
If you have any exposure to Greenlane — as an investor, a supplier, or a retail buyer — here are the practical things to watch:
- 10-Q and 10-K filings: Look for “going concern” language, which is an auditor’s formal warning that a company may not survive the next 12 months. Also check cash on hand and how fast it is declining.
- Press releases on financing: If Greenlane announces another private placement or emergency equity raise, that signals cash is running low again.
- Nasdaq notices: Any new compliance notices or delisting warnings would be public information and critical signals.
- BeraStrategy updates: Watch for whether this pivot is generating actual returns or continuing to contribute to losses.
The practical markers of a company getting very close to failure are: running out of cash with no new financing in sight, defaulting on debt obligations, or filing for Chapter 11 or Chapter 7 protection. None of those have happened yet. But the trajectory is not reassuring.
For broader context on how businesses navigate financial distress and what warning signs to watch across industries, resources like Drafted Business cover these topics in practical terms for entrepreneurs and managers.
The Bottom Line
Greenlane Holdings is not officially going out of business as of mid-2025. But it is in severe financial distress by nearly every measurable standard. A $4.4 million revenue base supporting over $85 million in annual losses is not sustainable. A 1-for-750 reverse stock split is not a recovery story. And a pivot from cannabis accessories to a Berachain treasury strategy is a high-risk bet, not a proven turnaround plan.
The company is surviving on outside financing and hope that the digital asset strategy eventually delivers. Whether that happens or not, the situation warrants watching closely — not assuming things will be fine, and not assuming they have already collapsed.
Keep an eye on the filings. The next quarterly report will tell you more than any press release will.
Also Read:
